Ludwikowska, K.M.; Tokarczyk, M.; Paleczny, B.; Tracewski, P.; Szenborn, L.; Kusa, J.
Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions. Int. J. Mol. Sci. 2024, 25, 8781.
https://doi.org/10.3390/ijms25168781
AMA Style
Ludwikowska KM, Tokarczyk M, Paleczny B, Tracewski P, Szenborn L, Kusa J.
Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions. International Journal of Molecular Sciences. 2024; 25(16):8781.
https://doi.org/10.3390/ijms25168781
Chicago/Turabian Style
Ludwikowska, Kamila Maria, Monika Tokarczyk, Bartłomiej Paleczny, Paweł Tracewski, Leszek Szenborn, and Jacek Kusa.
2024. "Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions" International Journal of Molecular Sciences 25, no. 16: 8781.
https://doi.org/10.3390/ijms25168781
APA Style
Ludwikowska, K. M., Tokarczyk, M., Paleczny, B., Tracewski, P., Szenborn, L., & Kusa, J.
(2024). Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions. International Journal of Molecular Sciences, 25(16), 8781.
https://doi.org/10.3390/ijms25168781
